2023
DOI: 10.3390/axioms12020184
|View full text |Cite
|
Sign up to set email alerts
|

Mathematical Modeling of the Tumor–Immune System with Time Delay and Diffusion

Abstract: This paper proposes a partial differential equation model based on the model introduced by V. A. Kuznetsov and M. A. Taylor, which explains the dynamics of a tumor–immune interaction system, where the immune reactions are described by a Michaelis–Menten function. In this work, time delay and diffusion process are considered in order to make the studied model closer to reality. Firstly, we analyze the local stability of equilibria and the existence of Hopf bifurcation by using the delay as a bifurcation paramet… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 19 publications
0
1
0
Order By: Relevance
“…Many mathematical models of tumor-immune dynamics have been developed (Eladdadi et al (2014); Sardar et al (2024); Cherraf et al (2023); Song et al (2021); Liu et al (2021); Yin et al (2019); Nikolopoulou et al (2018); Lai and Friedman (2017); de Pillis et al (2005); De Pillis and Radunskaya (2003)), including a few that focus specifically on GBM (Anderson et al (2023); Santurio and Barros (2022); Khajanchi (2021); Storey et al (2020)). Here, we extend the ODE model of Anderson et al (2023), which incorporates tumor cells, T cells, and MDSCs, to include treatment with anti-PD-1 and a CCR2 antagonist and subsequently apply optimal control theory.…”
Section: Introductionmentioning
confidence: 99%
“…Many mathematical models of tumor-immune dynamics have been developed (Eladdadi et al (2014); Sardar et al (2024); Cherraf et al (2023); Song et al (2021); Liu et al (2021); Yin et al (2019); Nikolopoulou et al (2018); Lai and Friedman (2017); de Pillis et al (2005); De Pillis and Radunskaya (2003)), including a few that focus specifically on GBM (Anderson et al (2023); Santurio and Barros (2022); Khajanchi (2021); Storey et al (2020)). Here, we extend the ODE model of Anderson et al (2023), which incorporates tumor cells, T cells, and MDSCs, to include treatment with anti-PD-1 and a CCR2 antagonist and subsequently apply optimal control theory.…”
Section: Introductionmentioning
confidence: 99%